ECSP993020A - Terapia de combinacion para la fragilidad musculoesqueletica - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica

Info

Publication number
ECSP993020A
ECSP993020A ECSP993020A ECSP993020A EC SP993020 A ECSP993020 A EC SP993020A EC SP993020 A ECSP993020 A EC SP993020A EC SP993020 A ECSP993020 A EC SP993020A
Authority
EC
Ecuador
Prior art keywords
compositions
fragility
combination therapy
oxo
phenyl
Prior art date
Application number
Other languages
English (en)
Inventor
Hua Zhu Ke
David Duane Thompson
Lydia Codetta Pan
Mei Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993020 priority Critical patent/ECSP993020A/es
Publication of ECSP993020A publication Critical patent/ECSP993020A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a composiciones de combinación farmacéuticas y a procedimientos que contienen (-)-cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxil)-fenil)-5,6,7,8-tetrahidronaftalen-2-ol o una de sus sales farmacéuticamente aceptables y 2-aminoN-(2-(3a R-bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo [4,3-c] piridin-5-il) -1R-benciloximetil-2-oxo-etil)-isobutiramida o una de sus sales farmacéuticamente aceptables, a procedimientos para usar tales composiciones y a estuches que contienen tales composiciones. Las composiciones son de utilidad para tratar fragilidad musculoesquelética, incluyendo osteoporosis, fractura osteoporótica, masa osea reducida, fragilidad y masa muscular reducida.
ECSP993020 1999-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica ECSP993020A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993020 ECSP993020A (es) 1999-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993020 ECSP993020A (es) 1999-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica

Publications (1)

Publication Number Publication Date
ECSP993020A true ECSP993020A (es) 1999-08-12

Family

ID=42044009

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993020 ECSP993020A (es) 1999-06-16 1999-06-16 Terapia de combinacion para la fragilidad musculoesqueletica

Country Status (1)

Country Link
EC (1) ECSP993020A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11723902B2 (en) 2014-09-04 2023-08-15 Helsinn Healthcare Sa Medical treatments based on anamorelin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11723902B2 (en) 2014-09-04 2023-08-15 Helsinn Healthcare Sa Medical treatments based on anamorelin

Similar Documents

Publication Publication Date Title
PL358004A1 (en) Pteridine compounds for the treatment of psoriasis
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
LU91710I2 (fr) Pazopanib, facultativement sous forme d'un sel ou d'un solvate pharmaceutiquement acceptable de celui-ci
BR9714155A (pt) Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina.
MY134480A (en) 4-pyrrolidino-phenyl-benzyl ether derivatives
BR0105457A (pt) Combinações terapêuticas para estimulação do crescimento ósseo
SE0101322D0 (sv) Novel compounds
PA8475901A1 (es) Terapia de combinacion para la fragilidad musculoesqueletica
CO5070584A1 (es) Composicion farmaceutica que comprende (-)-cis-6-fenil-5-(4- (2-pirrolidin-1-il-etoxi)-fenil)-5,6,7,8-tetrahidronaftalen -2-ol y hormona paratiroidea
UY25557A1 (es) Combinaciones terapeúticas para la fragilidad musculoesquelética
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
MXPA02001204A (es) Compuestos calciliticos.
IL158186A0 (en) Pharmaceutically active compounds and methods of use
MEP5608A (xx) Nova upotreba (r) – (-)-2-[5-(4-fluorofenil)-3-piridil- metilaminometil] - hromana i njegovih fiziološko prihvatljivi h soli
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
DE69916932D1 (de) Kombinationstherapeutika, enthaltend einen selektiven Östrogenrezeptormodulator und Prostaglandin E2
AU2003270164A1 (en) Kit for the therapy of capital and subcapital humerus fractures and humerus head prostheses
ECSP993016A (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratoroidea
AU2002361254A8 (en) Tracking early indicia of beauty treatment progress
AU2002339076A1 (en) Alkane diol derivatives as therapeutic agents for the treatment of bone conditions